Package 68999-841-24

{"route": ["ORAL"], "spl_id": "46dc543c-d51b-4dee-e063-6394a90a1856", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["e74bb389-8426-4ffc-a14b-a5990de6d0d4"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Chartwell Governmental & Specialty RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (68999-841-24)  / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-841-45)", "package_ndc": "68999-841-24", "marketing_start_date": "20251219"}], "brand_name": "Oxcarbazepine", "product_id": "68999-841_46dc543c-d51b-4dee-e063-6394a90a1856", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68999-841", "generic_name": "Oxcarbazepine", "labeler_name": "Chartwell Governmental & Specialty RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/5mL"}], "application_number": "ANDA212428", "marketing_category": "ANDA", "marketing_start_date": "20210921", "listing_expiration_date": "20261231"}